Efficacy and safety of low-dose prophylaxis of highly purified plasma-derived factor VIII concentrate produced by the National Blood Centre, Thai Red Cross Society

Ampaiwan ChuansumritDarintr SosothikulRungrote NatesirinilkulYujinda LektrakulUbonwon CharoonruangritKanhati ChiengthonKwannut SrikalaPakawan WongwerawattanakoonPraguywan KadegasemPintira TanthienSoisaang PhikulsodSomjai SittipreechacharnSappasitthiprasong HospitalThai Red Cross AgencyChulalongkorn UniversityFaculty of Medicine, Ramathibodi Hospital, Mahidol UniversityChiang Mai University2019-08-232019-08-232018-09-01Haemophilia. Vol.24, No.5 (2018), e387-e39013652516135182162-s2.0-85052645887https://repository.li.mahidol.ac.th/handle/20.500.14594/46411Mahidol UniversityMedicineEfficacy and safety of low-dose prophylaxis of highly purified plasma-derived factor VIII concentrate produced by the National Blood Centre, Thai Red Cross SocietyLetterSCOPUS10.1111/hae.13601